Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Completed · Phase 3

Conditions studied: Restless Legs Syndrome

In brief

A 12 week clinical trial was conducted in the United States in order to compare pramipexole (Mirapex®) versus placebo for the ability to reduce the symptoms of restless legs syndrome in adult subjects.

Key facts

Study ID
NCT00133198
Run by
Boehringer Ingelheim
People needed
345
Starts
2004-04-01
Expected to finish
2005-02-01
Last updated by the study team
2013-11-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.